Mitochondrial fission in apoptosis, neurodegeneration and aging.
A decline in mitochondrial function is well recognized in neurodegenerative diseases and aging, and is thought to play a causal role in their biology. Unfortunately, the molecular basis underlying this detrimental loss in mitochondrial function remains mysterious. Interestingly, mitochondria undergo frequent fission and fusion. This process is regulated by molecular machinery that has been highly conserved during evolution, including dynamin-related GTPases that manifest opposing effects. A balance between mitochondrial fission and fusion events is required for normal mitochondrial and cellular function. Emerging evidence indicates that mitochondria undergo rapid and extensive fission at an early stage during apoptosis. A clue that these new findings are of significance for the pathogenesis of neurodegenerative disease is provided by the observation that OPA-1, a dynamin-related GTPase regulating mitochondrial fusion, is mutated in humans with dominant optic atrophy, which is characterized by degeneration of retinal ganglion cells and childhood blindness. Loss of function of OPA-1, analogous to deficiency of its yeast homologue, Mgm1p, is expected to lead to mitochondrial fission, loss of mitochondrial DNA, respiratory deficits and an increase in reactive oxygen species. Here we review the molecular mediators controlling mitochondrial fission and fusion, and how death effector molecules may hijack this ancient machinery. A shift in the rate of mitochondrial fission or fusion may provide a new mechanistic explanation for the mitochondrial dysfunction in neurodegenerative diseases and normal aging, and may offer a new target for therapeutic intervention.
Bossy-Wetzel
Ella
E
Del E. Webb Center for Neuroscience and Aging The Burnham Institute, 10901 North Torrey Pines Rd, La Jolla, CA 92037, USA. ebossy-wetzel@burnham.org
Barsoum
Mark J
MJ
Godzik
Adam
A
Schwarzenbacher
Robert
R
Lipton
Stuart A
SA
D000375:Aging; D000818:Animals; D017209:Apoptosis; D017173:Caenorhabditis elegans; D004247:DNA / Q000737:chemistry; D004330:Drosophila; D020558:GTP Phosphohydrolases / Q000378:metabolism; D006801:Humans; D008928:Mitochondria / Q000378:metabolism / Q000473:pathology*; D008954:Models, Biological; D008957:Models, Genetic; D009154:Mutation; D019636:Neurodegenerative Diseases / Q000473:pathology; D017434:Protein Structure, Tertiary
D004247:DNA; D020558:GTP Phosphohydrolases; C415198:OPA1 protein, human